Citation:Wang F, Fang P, Hou DY, Leng ZJ, Cao LJ 2014

From Cancer Guidelines Wiki

Citation


Wang F, Fang P, Hou DY, Leng ZJ, Cao LJ. Comparison of epidermal growth factor receptor mutations between primary tumors and lymph nodes in non-small cell lung cancer: a review and meta-analysis of published data. Asian Pac J Cancer Prev 2014;15(11):4493-7 Available from: http://www.ncbi.nlm.nih.gov/pubmed/24969875.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Wang F, Fang P, Hou DY, Leng ZJ, Cao LJ 2014What specimen types are suitable for mutation testing in NSCLC patients?Associate Professor Wendy Coopercompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What specimen types are suitable for mutation testing in NSCLC patients?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What specimen types are suitable for mutation testing in NSCLC patients?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. What specimen types are suitable for mutation testing in NSCLC patients?
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Wang_F,_Fang_P,_Hou_DY,_Leng_ZJ,_Cao_LJ_2014&oldid=112633"